JPMorgan Chase & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $664M | Buy |
|
|||||
|
2025
Q2 | $536M | Buy |
|
|||||
|
2025
Q1 | $295M | Buy |
|
|||||
|
2024
Q4 | $187M | Sell |
|
|||||
|
2024
Q3 | $173M | Sell |
|
|||||
|
2024
Q2 | $325M | Buy |
|
|||||
|
2024
Q1 | $317M | Buy |
|
|||||
|
2023
Q4 | $229M | Sell |
|
|||||
|
2023
Q3 | $204M | Sell |
|
|||||
|
2023
Q2 | $185M | Sell |
|
|||||
|
2023
Q1 | $218M | Sell |
|
|||||
|
2022
Q4 | $259M | Sell |
|
|||||
|
2022
Q3 | $252M | Sell |
|
|||||
|
2022
Q2 | $292M | Sell |
|
|||||
|
2022
Q1 | $282M | Buy |
|
|||||
|
2021
Q4 | $254M | Buy |
|
|||||
|
2021
Q3 | $258M | Buy |
|
|||||
|
2021
Q2 | $141M | Sell |
|
|||||
|
2021
Q1 | $149M | Buy |
|
|||||
|
2020
Q4 | $91.4M | Buy |
|
|||||
|
2020
Q3 | $74.8M | Buy |
|
|||||
|
2020
Q2 | $88.1M | Buy |
|
|||||
|
2020
Q1 | $40M | Buy |
|
|||||
|
2019
Q4 | $4.69M | Buy |
|
|||||
|
2019
Q3 | $2.85M | Buy |
|
|||||
|
2019
Q2 | $961K | Sell |
|
|||||
|
2019
Q1 | $54M | Buy |
|
|||||
|
2018
Q4 | $18.8M | Buy |
|
|||||
|
2018
Q3 | $26.6M | Sell |
|
|||||
|
2018
Q2 | $46.3M | Buy |
|
|||||
|
2018
Q1 | $38.4M | Sell |
|
|||||
|
2017
Q4 | $42.1M | Buy |
|
|||||
|
2017
Q3 | $31.5M | Sell |
|
|||||
|
2017
Q2 | $26.7M | Sell |
|
|||||
|
2017
Q1 | $35.1M | Sell |
|
|||||
|
2016
Q4 | $37.3M | Sell |
|
|||||
|
2016
Q3 | $51.3M | Sell |
|
|||||
|
2016
Q2 | $56.7M | Buy |
|
|||||
|
2016
Q1 | $26M | Buy |
|
|||||
|
2015
Q4 | $31.3M | Buy |
|
|||||
|
2015
Q3 | $10.7M | Sell |
|
|||||
|
2015
Q2 | $13.3M | Buy |
|
|||||
|
2015
Q1 | $7.86M | Buy |
|
|||||
|
2014
Q4 | $2.53M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $2.26M | Buy |
|
|||||
|
2013
Q4 | $1.2M | Sell |
|
|||||
|
2013
Q3 | $1.89M | Sell |
|
|||||
|
2013
Q2 | $2.36M | Buy |
|